Article

Diagnostic potential of Stokes Shift spectroscopy of breast and prostate tissues-- a preliminary pilot study.

PG and Research Department of Physics, Jamal Mohamed College (Autonomous), Tiruchirappalli - 620020, Tamilnadu, India.
Technology in cancer research & treatment (Impact Factor: 1.94). 04/2011; 10(2):153-61.
Source: PubMed

ABSTRACT Stokes Shift (SS) Spectroscopy (SSS) of normal and abnormal breast and prostate tissues were studied. SS spectra is measured by simultaneously scanning both the excitation and emission wavelengths while keeping a fixed wavelength interval of Δλ = 20 nm. Characteristic, highly resolved peaks and significant spectral differences between normal and different pathological tissues of breast and prostate tissues were observed. The SS spectra of normal and different pathological breast and prostate tissues show the distinct peaks around 300, 350, 450, 500 and 600 nm may be attributed to tryptophan, collagen, NADH, flavin and porphyrin, respectively. Results of the current study demonstrate that the SS spectral changes due to tryptophan, collagen, hemoglobin, NADH, FAD and porphyrin have good diagnostic potential; therefore can be targeted as native tumor markers.

0 0
 · 
1 Bookmark
 · 
68 Views
  • Source
    [show abstract] [hide abstract]
    ABSTRACT: Stokes Shift Spectroscopy (S3) offers a novel way to rapidly measure spectral fingerprints of complex molecular mixtures in tissue. The changes of key fluorophores from normal state to the malignant state can be reflected by alteration of Stokes Shift Spectra (S3 spectra). S3 measurements can be used to acquire enough information of different key fluorophores from one spectrum to speed up spectral acquisition time. In this study, we demonstrate the usefulness of the S3 technique to distinguish the malignant tissue from the normal prostate and breast tissues. The optimal wavelength shift constant (Δλ c) of S3 spectra measurements for prostate/breast cancer detection were determined to be 40 nm. The underlying physical and biological basis for S3 is discussed. For the first time, our work explicitly discloses how and why S3 is supreme in comparison with other conventional spectroscopic techniques.
  • Source
    [show abstract] [hide abstract]
    ABSTRACT: Optical biopsy' is a novel method that uses spectroscopy at selected wavelengths to diagnose disease such as cancer and atherosclerosis without removing tissue from the body, offering a new armamentarium. This chapter provides an overview and focuses on how the spectroscopy from key native molecules in tissues reveals the differences between cancerous and normal tissues of various organs due to morphological and molecular changes in the tissue. The key optical methods are: fl uorescence, Stokes shift, elastic backscattering refl ectance, Raman, and time-resolved spectroscopies. These will be reviewed as useful tools in optical biopsy. Various human tissue types (prostate, breast, lung, colon, and gastrointestinal) have been studied using optical biopsy. The underlying physical and biological basis for these optical approaches will be discussed with examples.
    10/2013: pages 325-367; , ISBN: ISBN 978-0-85709-237-3
  • Source
    [show abstract] [hide abstract]
    ABSTRACT: The fluorophores of malignant human breast cells change their compositions that may be exposed in the fluorescence spectroscopy and blind source separation method. The content of the fluorophores mixture media such as tryptophan, collagen, elastin, NADH, and flavin were varied according to the cancer development. The native fluorescence spectra of these key fluorophores mixture media excited by the selective excitation wavelengths of 300 nm and 340 nm were analyzed using a blind source separation method: Nonnegative Matrix Factorization (NMF). The results show that the contribution from tryptophan, NADH and flavin to the fluorescence spectra of the mixture media is proportional to the content of each fluorophore. These data present a possibility that native fluorescence spectra decomposed by NMF can be used as potential native biomarkers for cancer detection evaluation of the cancer.

Full-text

View
16 Downloads
Available from
Nov 2, 2013